Martine Zimmermann, Vice President Global Regulatory Affairs, Alexion Pharmaceuticals joined us last year at the World Orphan Drug Congress Europe to present on ‘Ultra-rare skills for ultra-orphan success’ Download this presentation now to find out more about: What skills are required for overcoming the challenges in ultra-orphan drug development The importance of always keeping the focus on the end goal: the patient How together we can reach new heights in innovation for ultra-rare diseases …And much more! Get your copy here! If you are interested in finding out more about ultra-orphan drug development, then join us at the 5th Annual World Orphan Drug Congress.
Martine Zimmermann, Vice President Global Regulatory Affairs, Alexion Pharmaceuticals joined us last year at the World Orphan Drug Congress Europe to present on ‘Ultra-rare skills for ultra-orphan success’
Download this presentation now to find out more about:
What skills are required for overcoming the challenges in ultra-orphan drug development The importance of always keeping the focus on the end goal: the patient How together we can reach new heights in innovation for ultra-rare diseases
…And much more!
Get your copy here!
If you are interested in finding out more about ultra-orphan drug development, then join us at the 5th Annual World Orphan Drug Congress.
Remember my details
Privacy statement » Manage your email preferences »
You will be emailed the document as an attachment (2,521Kb in size)